Semaglutide is prescribed either in combination with other diabetes medications, like metformin, or as a standalone therapy
Keep product in cool, dark place unmixed until needed
if clinical criteria werent met, provide additional evidence or explain why criteria should be waived
some fraction of topically applied GHK-Cu may be cleaved before meaningful penetration occurs
Monitoring and assessment should include: Thyroid function tests (TSH, free T4) approximately 68 weeks after starting or adjusting levothyroxine, then at least annually once stable HbA1c measurements every 36 months to assess long-term glucose control Regular blood glucose monitoring as advised by your diabetes care team Annual kidney function tests (eGFR) and urine albumin-to-creatinine ratio Annual lipid profiles and cardiovascular risk assessment Monitoring for symptoms of either condition worsening Lifestyle modifications benefit both conditions significantly
For lipedema patients, who often face unique weight and fat distribution challenges, GLP-1 medications offer an additional tool for managing symptoms and improving overall health